Canbiola, Inc. (OTC Markets: CANB)
Canbiola, Inc. is a US Company specializing in the sale of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrate and water. Canbiola is developing their own line of proprietary products as well as seeking synergistic value through acquisitions in the Hemp Industry.
Canbiola aims to be the premier provider of the highest quality Hemp natural products on the market through sourcing the very best raw material and developing a variety of products they believe will improve people’s lives in a variety of areas.
The following Press Release(s) have not been investigated by Penny Stock Tweets, therefore, we have no idea if the content of the news release is based on Fact or Fiction. Although the link for the following press release may be from a familiar and reputable news source, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Penny Stock Tweets will not be held responsible for any news release, including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release. You should know that press releases found to be questionable can result in a trading halt, by the SEC of the securities in question. Said halt can result in a total loss of investment.
ISBG Signs Letter of Intent with Canbiola (CANB) for Premium CBD-Infused Beverage Partnership
LAS VEGAS, NV, Sept. 11, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — International Spirits and Beverage Group Inc. (OTCQB:ISBG) (“ISBG” or the “Company”), a top-tier brand incubator in the Global Wine & Spirits market, is excited to announce that it has signed a letter of intent (“LOI”) with Canbiola, Inc. (OTCMKTS: CANB) (“Canbiola”), a U.S. Company specializing in the sale of premium CBD-based products, for CANB to provide hemp extracted CBD for inclusion in our new line of CBD-infused alcoholic and non-alcoholic beverages, as well as CBD Chews, for sale in North America.
In line with a wave of recent strategic investments, the Company is convinced that the CBD-infused beverage market represents an enormous opportunity within the CBD and craft spirits twin booms.
CEO and Medical Adviser of Canbiola, Inc., Discuss Company Updates with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
PHOENIX, Aug. 07, 2018 (GLOBE NEWSWIRE) — Canbiola (OTC: CANB) (the “Company”) announced CEO Marco Alfonsi and medical adviser, Dr. Bob Kornfeld’s interview on Uptick Newswire’s “Stock Day” Podcast.
Jolly began the interview by asking CEO Marco Alfonsi for an update on the company since last appearing on the show on June 6, 2018.
Alfonsi stated that Canbiola is a CBD company that deals with a 99.5% or higher pure isolate. The Company works with at least 100 doctor’s offices at this point with a very high success rate and are experiencing continued and rapid growth.
Alfonsi briefly mentioned the shareholder’s letter from mid-July, which indicated that Canbiola continues to engage strategic medical partners that have allowed the Company to penetrate new markets and exponentially grow its exposure. This has involved the training of sales teams, which has begun to show results.
Alfonsi indicated that Canbiola doubled revenues from its 1st quarter in its second quarter. He plans to expand the Company’s product line by the 4th quarter 2018.